- Home
- FENC vs JRS Comparison
FENC vs JRS Comparison
Compare FENC & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.50
Company Overview
Basic Information| Metric | FENC | JRS |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 223.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENC | JRS |
|---|---|---|
| Price | $6.50 | $8.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 133.5K | 50.6K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $7.12 |
| 52 Week High | $9.92 | $8.38 |
Technical Indicators
Market Signals| Indicator | FENC | JRS |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 63.85 |
| Support Level | $5.65 | $7.91 |
| Resistance Level | $8.09 | $8.24 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 48.51 | 80.00 |
Price Performance
Historical Comparison FENC
JRS
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.